Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: A multisite, open-label, randomised controlled trial in South Africa and Uganda

The Lancet HIV

Volumn 3, Issue 5, 2016, Pages e212-e220

  Barnabas, Ruanne V ^a,b,c   van Rooyen, Heidi ^d   Tumwesigye, Elioda ^e   Brantley, Justin ^a   Baeten, Jared M ^a,b   van Heerden, Alastair ^d,f   Turyamureeba, Bosco ^e   Joseph, Philip ^d   Krows, Meighan ^a   Thomas, Katherine K ^a   Schaafsma, Torin T ^a   Hughes, James P ^a   Celum, Connie ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c USA   (United States)

^d HUMAN SCIENCES RESEARCH COUNCIL   (South Africa)

^e Integrated Community Based Initiatives   (Uganda)

^f UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CIRCUMCISION; COMMUNITY HEALTH NURSING; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; POINT OF CARE TESTING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOUTH AFRICA; UGANDA; VIRUS TRANSMISSION; CLINICAL TRIAL; COMMUNITY CARE; COUNSELING; HIV INFECTIONS; MASS SCREENING; PATIENT REFERRAL; POINT OF CARE SYSTEM;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CIRCUMCISION, MALE; COMMUNITY HEALTH SERVICES; COUNSELING; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; POINT-OF-CARE SYSTEMS; REFERRAL AND CONSULTATION; SOUTH AFRICA; UGANDA;

EID: 84959893285     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(16)00020-5     Document Type: Article

References (29)

1. Geldsetzer P, Bloom D, Humair S, Bärnighausen T Copenhagen consensus perspective paper health-HIV/AIDS: benefits and costs of the HIV/AIDS targets for the post-2015 development agenda 2015, Copenhagen Consensus Center, Frederiksberg.
2. Anderson S-J, Cherutich P, Kilonzo N, et al. Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study. Lancet 2014, 384:249-256.
3. Weiss HA, Dickson KE, Agot K, Hankins CA Male circumcision for HIV prevention: current research and programmatic issues. AIDS 2010, 24(suppl 4):S61-S69.
4. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005, 2:e298.
5. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007, 369:643-656.
6. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007, 369:657-666.
7. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011, 365:493-505.
8. Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010, 375:2092-2098.
9. Sgaier SK, Reed JB, Thomas A, Njeuhmeli E Achieving the HIV prevention impact of voluntary medical male circumcision: lessons and challenges for managing programs. PLoS Med 2014, 11:e1001641.
10. Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 2013, 339:966-971.
11. Fast-Track: Ending the AIDS Epidemic by 2030 UNAIDS, (Dec 11, 2014). http://www.unaids.org/sites/default/files/media_asset/JC2686_WAD2014report_en.pdf.
12. Alsallaq RA, Baeten JM, Celum CL, et al. Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community. PloS One 2013, 8:e54575.
13. Sabapathy K, Van den Bergh R, Fidler S, Hayes R, Ford N Uptake of home-based voluntary HIV testing in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Med 2012, 9:e1001351.
14. Sharma M, Ying R, Tarr G, Barnabas R Systematic review and meta-analysis of community and facility-based HIV testing to address linkage to care gaps in sub-Saharan Africa. Nature 2015, 528:S77-S85.
15. Suthar AB, Ford N, Bachanas PJ, et al. Towards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of community-based approaches. PLoS Med 2013, 10:e1001496.
16. Wynberg E, Cooke G, Shroufi A, Reid SD, Ford N Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review. J Int AIDS Soc 2014, 17:18809.
17. Jani IV, Sitoe NE, Alfai ER, et al. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet 2011, 378:1572-1579.
18. van Rooyen H, Barnabas RV, Baeten JM, et al. High HIV testing uptake and linkage to care in a novel program of home-based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr 2013, 64:e1-e8.
19. Decroo T, Rasschaert F, Telfer B, Remartinez D, Laga M, Ford N Community-based antiretroviral therapy programs can overcome barriers to retention of patients and decongest health services in sub-Saharan Africa: a systematic review. Int Health 2013, 5:169-179.
20. Chamie G, Kwarisiima D, Clark TD, et al. Uptake of community-based HIV testing during a multi-disease health campaign in rural Uganda. PLoS One 2014, 9:e84317.
21. Finitsis DJ, Pellowski JA, Johnson BT Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials. PLoS One 2014, 9:e88166.
22. Lester RT, Ritvo P, Mills EJ, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet 2011, 376:1838-1845.
23. Barnabas RV, Van Rooyen H, Tumwesigye E, et al. Initiation of antiretroviral therapy and viral suppression after home HIV testing and counselling in KwaZulu-Natal, South Africa, and Mbarara district, Uganda: a prospective, observational intervention study. Lancet HIV 2014, 1:e68-e76.
24. Tumwebaze H, Tumwesigye E, Baeten JM, et al. Household-based HIV counseling and testing as a platform for referral to HIV care and medical male circumcision in Uganda: a pilot evaluation. PLoS One 2012, 7:e51620.
25. Smith J, Sharma M, Levin C, et al. Community-based strategies to strengthen the continuum of HIV care are cost-effective in rural South Africa: a health economic modelling analysis. Lancet HIV 2015, 4:e159-e168.
26. Eaton JW, Menzies NA, Stover J, et al. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health 2014, 2:e23-e34.
27. Thirumurthy H, Chamie G, Jain V, et al. Improved employment and education outcomes in households of HIV-infected adults with high CD4 cell counts: evidence from a community health campaign in Uganda. AIDS 2013, 27:627-634.
28. MacPherson P, Lalloo DG, Webb EL, et al. Effect of optional home initiation of HIV care following HIV self-testing on antiretroviral therapy initiation among adults in Malawi: a randomized clinical trial. JAMA 2014, 312:372-379.
29. Delaugerre C, Ghosn J, Lacombe J, et al. Significant reduction in HIV virologic failure during a 15-year period in a setting with free healthcare access. Clin Infect Dis 2015, 60:463-472.